Table 1.
Characteristics | No. of Patients | 5-Year OS | 5-Year RFS | |||||
---|---|---|---|---|---|---|---|---|
Deaths, No. | Rate, % a | p b | Cases, No. | Rate, % a | p b | |||
Age at diagnosis, y | ≤60 | 19 | 2 | 88.9 | 0.048 | 3 | 84.2 | 0.21 |
61–69 | 64 | 9 | 83.4 | 14 | 72.4 | |||
70–79 | 81 | 15 | 78.7 | 12 | 81.4 | |||
≥80 | 33 | 11 | 61.5 | 1 | 96.3 | |||
Sex, n | Male | 102 | 23 | 74.3 | 0.18 | 17 | 77.5 | 0.48 |
Female | 95 | 14 | 83.2 | 13 | 84.0 | |||
Clinical stage, n | I | 47 | 3 | 92.5 | 0.001 | 5 | 88.4 | 0.09 |
II | 86 | 13 | 82.4 | 11 | 82.0 | |||
III | 64 | 21 | 63.5 | 14 | 73.8 | |||
Chemotherapy, n | Yes | 66 | 18 | 68.5 | 0.03 | 15 | 73.1 | 0.03 |
No | 131 | 19 | 83.7 | 15 | 85.0 | |||
Anatomic tumor location, n | Left | 99 | 17 | 81.2 | 0.42 | 19 | 77.2 | 0.23 |
Right | 98 | 20 | 75.6 | 11 | 85.3 |
a Survival rates were calculated by the Kaplan–Meier estimation method. b p value of Log–rank test.